Benzinga | Jul 30, 2021 07:11AM EDT

SVB Leerink Maintains Outperform on Gilead Sciences, Raises Price Target to $77

SVB Leerink analyst Geoffrey Porges maintains Gilead Sciences (NASDAQ:GILD) with a Outperform and raises the price target from $74 to $77.